zes our experience as an Affiliate site for an NIH Grant held by the University of Southern California. This study began in 1994 in the Medical Tower with David S. H. Bell, M.D. as the Primary Investigator and Joy Atchison, M.D. as Co-Investigator. The study originally began with Screening for Islet Cell Antibodies (ICA) and Staging to determine if siblings or immediate family of newly diagnosed Type 1 diabetics were at risk of developing the disease. Subjects with a positive ICA test were then asked to participate in the Staging Process to determine if they were at low, moderate or high risk for developing diabetes as indicated by the amount of Islet Cell Antibodies present. The study was subsequently renewed on April 12, 1995. In January of 1996, Dr. Joy Atchison, M.D., became the Principal Investigator and the study was moved from the Medical Towers facility to Children's Hospital. In February 1996 an Intervention phase was added to the Study. The Intervention Phase was approved by the IRB on February 14, 1996. The Intervention Phase was parenteral insulin and oral insulin testing as a preventive measure against the development of Type 1 Diabetes. Those with a 25-50% risk or moderate risk would be randomized to parenteral insulin or no insulin group. In March of 1999 Fernando Ovalle, M.D. took over as the Principal Investigator of the study when Dr. Atchison left Children's Hospital to go into private practice. The study remained at Children's Hospital until October of 1999 when the coordination changed to the Division of Endocrinology and Metabolism, Clinical Trials Unit, notification of the change was sent to the IRB. Subjects continue to be screened at Children's Hospital but, are now staged at the General Clinical Research Center (GCRC), housed in the West Pavilion. Administration and Coordination for the study, Case Report Forms, Charts and Regulatory Documents are now housed in the Division of Endocrinology and Metabolism, Clinical Trials Unit on the 8th floor of the Diabetes Research and Education Building in room 817.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000032-40
Application #
6406892
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
1978-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
40
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Yu, Alan S L; Shen, Chengli; Landsittel, Douglas P et al. (2018) Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int 93:691-699
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
McKenzie, Katelyn A; El Ters, Mirelle; Torres, Vicente E et al. (2018) Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. BMC Nephrol 19:378
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Morrison, Shannon A; Goss, Amy M; Azziz, Ricardo et al. (2017) Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome. Hum Reprod 32:185-192
Shen, Chengli; Landsittel, Douglas; Irazabal, María V et al. (2017) Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis 69:482-484
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
Kline, Timothy L; Korfiatis, Panagiotis; Edwards, Marie E et al. (2017) Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. Kidney Int 92:1206-1216
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628

Showing the most recent 10 out of 570 publications